Adam John Pearson
Chief Strategy Officer
|
Atsushi Kamide
Manager-Public Relations
|
Catherine Levitt
General Counsel
|
Claudia Mitchell
Senior VP-Product & Portfolio Strategy
|
Claus Gerhard Zieler
Chief Commercial Officer
|
Eriko Sakurai
Outside Director
|
Haruko Shibumura
Outside Director
|
Hideki Shima
Chief Manufacturing Officer
|
Hideto Yamaguchi
Senior Director-Pharmaceutical Technologies
|
Hiroko Sakai
Director
|
Hiroo Sasaki
Outside Director
|
Hiroshi Kawabe
Independent Outside Director
|
Katsuyoshi Sugita
EVP, Chief People, Ethics & Compliance Officer
|
Kazunori Maruyama
Director-Innovation Management
|
Kei Motonaga
Sr Dir-Quality Control Div, Yaizu Technology Ctr
|
Keisuke Mitsuoka
Associate Director
|
Kenji Yasukawa
Chairman
|
Kitamura Atsushi
Chief Financial Officer
|
Luiz Dutra
Managing Director-Astellas Farma Brasil
|
Mamoru Sekiyama
Independent Outside Director
|
Masahide Goto
President-Astellas Institute-Regenerative Medicine
|
Mika Nakayama
Outside Director
|
Naoki Okamura
President, CEO & Representative Director
|
Nick Eshkenazi
Chief Digital & Transformation Officer
|
Nobuaki Tanaka
Senior Executive Officer & General Manager-Sales
|
Nobue Yasuda
Manager-Accounting
|
Noriyuki Uematsu
Outside Director
|
Peter Sandor
VP, Head-Oncology Therapeutic Area in Mktg Strat
|
Ryosuke Munakata
Director
|
Shigeru Nakaji
Exec Dir-Japan-Asia Clinical Dev 1, Dev
|
SUMIHO NAKATSU
Associate Manager
|
Tadaaki Taniguchi
Chief Medical Officer
|
Takashi Tanaka
Outside Director
|
Taro Masunaga
Exec Dir-Incubation Rsch Labs, Drug Discovery Rsch
|
Tatsuro Ishizuka
Independent Outside Director
|
Tomokazu Fujisawa
Director
|
Tomoyuki Yasunaga
Staff Exec Dir-Plnng & Admin-Drug Discovery Rsch
|
Tyler Marciniak
Director-Oncology Communications & Advocacy
|
Yoshitsugu Shitaka
Chief Scientific Officer & Head-Research
|
